Effects of chronic β-adrenergic receptor stimulation in mice

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 10, 1997, Pages 2735-2746

  Kudej, Raymond K ^a   Iwase, Mitsunori ^a   Uechi, Masami ^a   Vatner, Dorothy E ^a   Oka, Naoki ^a   Ishikawa, Yoshihiro ^a   Shannon, Richard P ^a   Bishop, Sanford P ^b   Vatner, Stephen F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Adenylyl cyclase; Desensitization; Isoproterenol; Mouse; mRNA; adrenergic receptor

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; FORSKOLIN; HEART RECEPTOR; ISOPRENALINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONNECTIVE TISSUE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME REPRESSION; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; MUSCLE MASS; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

ANIMALIA;

EID: 0031259520     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0508     Document Type: Article

References (47)

1. ALLARD MF, DEVENNY MF, Doss LK, GRIZZLE WE, BISHOP SP, 1990. Alterations in dietary sodium affect isoproterenol-induced cardiac hypertrophy. J Mol Cell Cardiol 22: 1135-1145.
2. 3 and atypical β-adrenoceptors. Med Res Rev 13: 663-729.
3. BENJAMIN IJ, JALIL JE, TAN LB, CHO K, WEBER KT, CLARK WA, 1989. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65: 657-670.
4. BOWLING N, WYSS VL, GENGO PJ, UTTERBACK B, KAUFFMAN RF, HAYES JS, 1990. Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion. Eur J Pharmacol 187: 155-164.
5. BRILLA CG, PICK R, TAN LP, JANICKI JS, WEBER KT, 1990. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364.
6. CARPENE C, GALITZKY J, COLLON P, ESCLAPEZ F, DAUZATS M, LAFONTAN M, 1993. Desensitization of β-1 and β-2, but not β-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J Pharmacol Exp Ther 265: 237-247.
7. CHANG HY, KLEIN RM, KUNOS G, 1982. Selective desensitization of cardiac β-adrenoceptors by prolonged in vivo infusion of catecholamines in rats. J Pharmacol Exp Ther 221: 784-789.
8. CHOO JJ, HORAN MA, LITTLE RA, ROTHWELL NJ, 1992. Anabolic effects of clenbuterol on skeletal muscle are mediated by β-adrenoceptor activation. Am J Physiol 263: E50-E56.
9. oα mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol 42: 773-783.
10. GELEON A, COLLET AJ, GUAY G, BUKOWIECKI LJ, 1988. β-adrenergic stimulation of brown adipocyte proliferation. Am J Physiol 254: C175-C182.
11. GIANNUZZI CE, SEIDLER FJ, SLOTKIN TA, 1995. β-Adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 694: 271-278.
12. GORDON AL, INCHIOSA MA, LEHR D, 1972. Isoproterenol-induced cardiomegaly: assessment of myocardial protein content, actomyosin ATPase and heart rate. J Mol Cell Cardiol 4: 543-557.
13. GRANNEMAN JG, 1992. Effect of agonist exposure on the coupling of β-1 and β-3 adrenergic receptors to adenylyl cyclase in isolated adipocytes. J Pharmacol Exp Ther 261: 638-642.
14. HARDEN TK, 1983. Agonist-induced desensitization of the β-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev 35: 5-32.
15. HARRI MNE, VALTOLA J, 1975. Comparison of the effects of physical exercise, cold acclimation and repeated injections of isoprenaline on rat muscle enzymes. Acta Physiol Scand 95: 391-399.
16. HAYES JS, POLLOCK GD, FULLER RW, 1984. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol. J Pharmacol Exp Ther 231: 633-639.
17. HERTEL C, PERKINS, JP, 1984. Receptor-specific mechanisms of desensitization of β-adrenergic receptor function. Mol Cell Endocrinol 37: 245-256.
18. HITTINGER L, SHANNON RP, BISHOP SP, GELPI RJ, VATNER SF, 1989. Subendocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 65: 971-980.
19. HOIT BD, KHOURY SF, KRANIAS EG, BALL N, WALSH RA, 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 77: 632-637.
20. ISHIKAWA Y, SOROTA S, KIUCHI D, SHANNON RP, KOMAMURA K, KATSUSHIKA S, VATNER DE, VATNER SF, HOMCY CJ, 1994. Downregulation of adenylyl cyclase types V and VI mRNA levels in pacing-induced heart failure in dogs. J Clin Invest 93: 2224-2229.
21. sα overexpression. Circ Res 78: 517-524.
22. JALIL JE, JANICKI JS, PICK R, ABRAHAMS C, WEBER KT, 1989. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res 65: 258-264.
23. JEPPSSON AB, WALDECK B, WIDMARK E, 1986. Further studies on the cardiomegaly induced by β-adrenoceptor agonists. Acta Pharmacol Toxicol 58: 121-125.
24. KATSUSHIKA S, CHEN L, KAWABE J, NILAKANTAN R, HALNON NJ, HOMCY CJ, ISHIKAWA Y, 1992. Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc Natl Acad Sci USA 89: 8774-8778.
25. sα subunit levels in ventricular myocardium of rats treated with isoproterenol. Life Sci 53: PL171-PL176.
26. KIUCHI K, SHANNON RP, KOMAMURA K, COHEN DJ, BIANCHI C, HOMCY CJ, VATNER SF, VATNER DE, 1993. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 91: 907-914.
27. KURIBAYASHI T, FURUKAWA K, KATSUME H, IJICHI H, IBATA Y, 1986. Regional differences of myocyte hypertrophy and three-dimensional deformation of the heart. Am J Physiol 250: H378-H388.
28. LEBLANC J, VALLIERES J, VACHON C, 1972. β-receptor sensitization by repeated injections of isoproterenol and by cold adaptation. Am J Physiol 222: 1043-1046.
29. LORA-VILCHIS MC, CHAMBERT G, RODRIGUEZ-ZENDEJAS AM, SOTO-MORA LM, RUSSEK M, EPSTEIN AN, 1988. Ontogeny of α-and β-adrenergic anorexia in rats. Am J Physiol 255: R908-R913.
30. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
31. MARSH JD, BARRY WH, NEER EJ, ALEXANDER RW, SMITH TW, 1979. Desensitization of chick embryo ventricle to the physiological and biochemical effects of isoproterenol. Circ Res 45: 528-540.
32. MUNSON PJ, RODBARD D, 1980. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Chem 107: 220-239.
33. NANOFF C, FREISSMUTH M, TUISL E, SCHUTZ W, 1989. A different desensitization pattern of cardiac β-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J Cardiovasc Pharmacol 13: 198-203.
34. PEREZ-LLAMAS F, ZAMORA S, 1991. The influence of clenbuterol on growth in rats. Comp Biochem Physiol 99A: 241-244.
35. PREMONT RT, CHEN J, MA HW, PONNAPALLI M, IYENGAR R, 1992. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc Natl Acad Sci USA 89: 9809-9813.
36. RIETHMANN C, GIERSCHIK P, SIDEROPOLOUS D, WERDAN K, JAKOBS KH, 1989. Mechanism of noradrenaline-induced heterologous desensitization of adenylyl cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein α-subunits. Eur J Pharmacol (Mol Pharmacol) 172: 211-221.
37. ROBBINS RJ, SWAIN JL, 1992. C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice. Am J Physiol 262: H590-H597.
38. RONA G, 1985. Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306.
39. SAHN DJ, DEMARIA A, KISSLO J, WEYMAN A, 1978. Recommendations regarding quantitation in m-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
40. SALOMON Y, LONDOS C, RODBELL M, 1974. A highly sensitive adenylate cyclase assay. Anal Chem 58: 541-548.
41. SOONPAA MH, FIELD LJ, 1994. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 266: H1439-H1445.
42. STANTON HC, BRENNER G, MAYFIELD ED, 1969. Studies on isoproterenol-induced cardiomegaly in rats. Am Heart J 77: 72-80.
43. TSE J, POWELL JR, BASTE CA, PRIEST RE, KUO JF, 1979. Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of β-adrenergic receptor, adenylate cyclase, and ventricular contraction. Endocrinology 105: 246-255.
44. VATNER DE, VATNER SF, NEJIMA J, UEMURA N, SUSANNI EE, HINTZE TH, HOMCY, CJ, 1989. Chronic norepinephrine elicits desensitization by uncoupling the β-receptor. J Clin Invest 84: 1741-1748.
45. WEBER KT, BRILLA CG, 1991. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865.
46. YAMASHITA J, ONAI T, YORK DA, BRAY GA, 1994. Relationship between food intake and metabolic rate in rats treated with β-adrenoceptor agonists. Int J Obesity 18: 429-433.
47. YOSHIMURA M, COOPER DMF, 1992. Cloning and expression of a Ca inhibitable adenylyl cyclase from NCB-20 cells. Proc Natl Acad Sci USA 89: 6716-6720.